Clinical Trial Update: Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury [Phase 3]

View source ↗

Summary

Phase 3 trial update for Ronopterin (VAS203) in moderate to severe traumatic brain injury completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Ronopterin (vasoprotin? (Ronopterin is the chemical name; commonly referred as Ronopterin))

Snippet

Sponsor: veriNOS operations GmbH | Conditions: Traumatic Brain Injury | Phase 3 | Status: COMPLETED